Polynovo Limited (ASX:PNV)

Max Johnston
Interim CEO
Market Cap (AUD): 926.36M
Sector: Health Care
Last Trade (AUD): 1.355 -0.04 (-3.21%)
Tab Bar

1. About

PolyNovo Limited (ASX:PNV) develops innovative medical devices utilising the patented bioabsorbable polymer technology Novosorb.

NovoSorb is a family of proprietary medical grade polymers that can be expressed in a variety of physical formats. NovoSorb polymers have advantageous properties such as biocompatibility and design flexibility. These properties underpin novel medical devices designed to support tissue repair, before they biodegrade in situ into biocompatible by-products via established pathways.

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk